INTCO Medical Receives Three Prestigious Pharmaceutical Industry Awards

INTCO Medical has once again demonstrated its strong leadership in China’s healthcare and pharmaceutical manufacturing sector. Evolving from a global glove leader into a comprehensive medical enterprise, the company continues to earn industry-wide recognition for its solid business growth and continuous innovation.

Recognizing Excellence in Leadership and Performance

On November 10, at the 2024–2025 Annual Industry Conference organized by the China Chamber of Commerce for the Pharmaceutical Industry (CCPIE) under the All-China Federation of Industry and Commerce, Mr. Liu Fangyi, Chairman of INTCO Medical, was honored with the “Outstanding Contributor of the Year in the Pharmaceutical Industry” award.

This accolade acknowledges Mr. Liu’s exceptional vision, leadership, and influence in driving both corporate and sectoral progress within China’s rapidly advancing pharmaceutical landscape.

At the same conference, INTCO Medical also earned two additional distinctions: it was named among the “Top 100 Pharmaceutical Industrial Enterprises by Operating Revenue” and the “Top 50 Fastest-Growing Pharmaceutical Enterprises.”

These honors reaffirm INTCO Medical’s role as a benchmark for innovation, operational excellence, and sustainable development in the global medical manufacturing arena.

Authority and Impact of the CCPIE Awards

As one of China’s most influential industry organizations, the CCPIE conducts a comprehensive annual evaluation covering revenue scale, growth performance, innovation capacity, and overall contributions to the pharmaceutical industry. The awards celebrate enterprises and leaders that exemplify excellence, responsibility, and innovation in advancing China’s medical and healthcare development.

Driving Diversification and Globalization

Guided by Chairman Liu Fangyi, INTCO Medical has maintained its strategic foundation in disposable gloves, while steadily expanding into medical consumables, rehabilitation equipment, and physical therapy products.

Through continuous investment in intelligent manufacturing, production capacity, and global market expansion, the company has established itself as a trusted international brand committed to quality and technological advancement.

Strong Performance Reflecting Industry Leadership

In 2024, INTCO Medical achieved CNY 9.523 billion in operating revenue, representing a 37.65% year-on-year increase. During the first three quarters of 2025, the company reported CNY 7.425 billion, up 4.60% year-on-year—demonstrating exceptional resilience in a complex and evolving global market environment.

Today, INTCO Medical’s products are exported to more than 150 countries and regions across the Americas, Europe, Asia, Africa, and Oceania, serving over 15,000 clients worldwide with reliable, high-quality medical products and healthcare solutions.

Looking Ahead: Commitment to Innovation and Social Responsibility

Receiving these three major honors not only highlights Chairman Liu Fangyi’s enduring contributions to the healthcare sector but also reflects INTCO Medical’s leadership in promoting high-quality, sustainable growth within the pharmaceutical industry.

Moving forward, INTCO Medical will continue to advance its automation, digitalization, and intelligent manufacturing initiatives, strengthen R&D and innovation, and uphold its commitment to corporate social responsibility—driving global healthcare progress and contributing to the modernization of China’s pharmaceutical and medical industries.